Literature DB >> 10477842

Evidence of continuing bone recovery at a mean of 7 years after liver transplantation.

R B Feller1, J A McDonald, K J Sherbon, G W McCaughan.   

Abstract

Patients with end-stage liver disease have low bone-turnover osteoporosis, and there is often further bone loss of 20% to 30% after orthotopic liver transplantation (OLT). Bone recovery after OLT has been reported, but data are limited. We undertook studies to determine whether bone recovery continues in the long term. Twenty-eight adult patients alive at least 5 years after OLT were studied (14 men, 14 women). Bone mineral density (BMD), serum parathyroid hormone (PTH), osteocalcin, and vitamin D levels were measured pretransplantation, at 3 months, 12 months, a mean of 46 months, and a mean of 85 months (range, 63 to 117 months) after transplantation. When BMD is expressed as a z score, the results were as follows: x0.82 +/- 0.22 pre-OLT; -2.04 +/- 0.27 at 3 months; -1.68 +/- 0.24 at 12 months; -1.23 +/- 0.24 at a mean of 46 months; and -1.0 +/- 0.26 at a mean of 85 months after OLT. The results at 46 and 85 months were significantly greater than the measurement at 3 months after OLT (P <.05). Furthermore, mean BMD (expressed as a z score) returns to the pre-OLT level at a mean of 85 months. At final follow-up, 9 of 28 patients had elevated PTH levels, and 14 of 27 patients had elevated osteocalcin levels. Five patients had spontaneous fractures in the first 12 months after transplantation, and 5 more patients had fractures by final follow-up. Even at 7 years after OLT, there was a significant increase in BMD (expressed as a z score) compared with 3 months after transplantation. Elevation of serum PTH and osteocalcin levels in some patients suggests continuing bone remodeling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477842     DOI: 10.1002/lt.500050507

Source DB:  PubMed          Journal:  Liver Transpl Surg        ISSN: 1074-3022


  7 in total

Review 1.  Hepatic osteodystrophy.

Authors:  Angelo Gatta; Alberto Verardo; Marco Di Pascoli; Sandro Giannini; Massimo Bolognesi
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

2.  Treatment of osteoporosis in patients with chronic liver disease and in liver transplant recipients.

Authors:  Naim M Maalouf; Khashayar Sakhaee
Journal:  Curr Treat Options Gastroenterol       Date:  2006

3.  Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation.

Authors:  Peter P Reese; Roy D Bloom; Harold I Feldman; Ari Huverserian; Arwin Thomasson; Justine Shults; Takayuki Hamano; Simin Goral; Abraham Shaked; Kimberly Olthoff; Michael R Rickels; Melissa Bleicher; Mary B Leonard
Journal:  Liver Int       Date:  2011-09-09       Impact factor: 5.828

Review 4.  Post-renal transplantation hypophosphatemia.

Authors:  Khashayar Sakhaee
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

5.  Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation.

Authors:  F Atamaz; S Hepguler; M Akyildiz; Z Karasu; M Kilic
Journal:  Osteoporos Int       Date:  2006-03-21       Impact factor: 4.507

Review 6.  Osteoporosis after solid organ and bone marrow transplantation.

Authors:  Adi Cohen; Elizabeth Shane
Journal:  Osteoporos Int       Date:  2003-08-08       Impact factor: 4.507

7.  The impact of osteoporosis on health-related quality of life in patients after liver transplantation - a pilot study.

Authors:  Joanna Raszeja-Wyszomirska; Robert Kucharski; Katarzyna Kotarska; Marta Zalewska; Tomasz Miazgowski
Journal:  Prz Gastroenterol       Date:  2015-06-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.